- Recent Funding
- Investors
- Ackermans & van Haaren
Ackermans & van Haaren portfolio
Ackermans & van Haaren has 3 portfolio companies on record at Recent Funding.
About this page
It led 2 of the 4 rounds it joined. Its most recent investment on record is MRM Health's $64.12M Series B+ round in September 2025, alongside QBIC II, OMX Ventures, SFPIM and 3 others. By category, its portfolio leans toward Health and bio (3). It has co-invested with VIB, EQT Life Sciences and Eurazeo, most often VIB (2 rounds).
What Ackermans & van Haaren invests in
- Health and bio · 3 · 100%
Ackermans & van Haaren recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $64.12M | QBIC II, OMX Ventures, SFPIM +3 | ||
| Series B+ · $65M · lead | MINTS, Fund+, Wellington Management +7 | ||
| Series B+ · $71M | EQT Life Sciences, Droia Ventures, Eurazeo +4 | ||
| Series B+ · lead | EQT Life Sciences, Droia Ventures, Eurazeo +3 |
How Ackermans & van Haaren invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 4 100% | $200.12M |
Ackermans & van Haaren portfolio companies
MMRM Health$64.12MSeries B+ · Sep 2025
CConfo Therapeutics$65MSeries B+ · Aug 2024
VVico Therapeutics$71MSeries B+ · Jun 2024
| Company | Round with Ackermans & van Haaren | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $64.12M | $64.12M | Sep 4, 2025 Series B+ |
Health and bio |
Series B+ · $65M · lead | $99M | Aug 5, 2024 Series B+ |
Health and bio |
Series B+ · $71M | $71M | Jun 24, 2024 Series B+ |
Most frequent co-investors
VVIB2 shared rounds · last Sep 4, 2025
EEQT Life Sciences2 shared rounds · last Jun 24, 2024
EEurazeo2 shared rounds · last Jun 24, 2024
PPolaris2 shared rounds · last Jun 24, 2024
KKurma Partners2 shared rounds · last Jun 24, 2024
DDroia Ventures2 shared rounds · last Jun 24, 2024
PPureos Bioventures2 shared rounds · last Jun 24, 2024
SSFPIM1 shared round · last Sep 4, 2025
OOMX Ventures1 shared round · last Sep 4, 2025
- QQBIC II1 shared round · last Sep 4, 2025
BBNP Paribas Fortis1 shared round · last Sep 4, 2025
BBIOCODEX1 shared round · last Sep 4, 2025
Similar investors
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 4 rounds on Recent Funding that name Ackermans & van Haaren. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Ackermans & van Haaren, which is a subset of its real portfolio. API: /api/v1/investors/ackermans-van-haaren (get a free API key). More: the most active VC firms and new venture capital funds.